SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-19-015293
Filing Date
2019-03-15
Accepted
2019-03-15 16:17:07
Documents
79
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a19-30101_110k.htm 10-K 2035494
2 EX-21.1 a19-30101_1ex21d1.htm EX-21.1 1574
3 EX-23.1 a19-30101_1ex23d1.htm EX-23.1 5777
4 EX-31.1 a19-30101_1ex31d1.htm EX-31.1 11528
5 EX-31.2 a19-30101_1ex31d2.htm EX-31.2 11528
6 EX-32.1 a19-30101_1ex32d1.htm EX-32.1 5156
7 EX-32.2 a19-30101_1ex32d2.htm EX-32.2 5150
14 GRAPHIC g301011bqi001.gif GRAPHIC 18910
  Complete submission text file 0001104659-19-015293.txt   9240113

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stml-20181231.xml EX-101.INS 2300310
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20181231.xsd EX-101.SCH 60721
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20181231_cal.xml EX-101.CAL 60780
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20181231_def.xml EX-101.DEF 211104
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20181231_lab.xml EX-101.LAB 573527
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20181231_pre.xml EX-101.PRE 404135
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35619 | Film No.: 19685265
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences